Stock Price
13.51
Daily Change
0.42 3.21%
Monthly
9.22%
Yearly
22.37%
Q1 Forecast
12.69

Viatris reported $0.67 in EPS Earnings Per Share for its fiscal quarter ending in September of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q4 Dec/2025 0.53 0.54 Mar/02 2026
FY2025Q3 Sep/2025 0.67 0.62 0.75 Nov/06 2025
FY2025Q2 Jun/2025 0.62 0.55 0.69 Aug/07 2025
FY2025Q1 Mar/2025 0.50 0.53 0.67 May/08 2025
FY2024Q4 Dec/2024 0.54 0.58 -0.64 Feb/27 2025




Eps Change Date
Celltrion KRW 1.13K 317.83 Sep/2025
Cspc Pharmaceutical CNY 0.08 0.01 Sep/2025
Dianthus Therapeutics USD -0.97 0.09 Sep/2025
Divis Laboratories Ltd INR 25.97 5.48 Sep/2025
Kangmei Pharma CNY 0 0 Sep/2025
Knight Therapeutics CAD -0.03 0.07 Jun/2025
Laboratorios Farma EUR 1.96 0.71 Dec/2023
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 0 0 Jun/2025
Neuren Pharmaceuticals AUD 0.06 0.97 Jun/2025
Organigram Holdings CAD -0.18 0.13 Sep/2025
Pharma Mar EUR -0.23 1.55 Sep/2025
Qiagen NV USD 0.53 0.07 Sep/2025
Sartorius EUR 0.63 0.16 Sep/2025
Sino Biopharmaceutical CNY 0.16 0.07 Jun/2025
Tilray USD -0.41 0.4 Dec/2025
Viatris USD 0.67 0.05 Sep/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 1.53 0.8 Sep/2025